1. Home
  2. NAII vs CODX Comparison

NAII vs CODX Comparison

Compare NAII & CODX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAII
  • CODX
  • Stock Information
  • Founded
  • NAII 1980
  • CODX 2013
  • Country
  • NAII United States
  • CODX United States
  • Employees
  • NAII N/A
  • CODX N/A
  • Industry
  • NAII Medicinal Chemicals and Botanical Products
  • CODX Medical/Dental Instruments
  • Sector
  • NAII Health Care
  • CODX Health Care
  • Exchange
  • NAII Nasdaq
  • CODX Nasdaq
  • Market Cap
  • NAII 26.0M
  • CODX 22.0M
  • IPO Year
  • NAII 1987
  • CODX 2017
  • Fundamental
  • Price
  • NAII $4.05
  • CODX $0.71
  • Analyst Decision
  • NAII
  • CODX Hold
  • Analyst Count
  • NAII 0
  • CODX 1
  • Target Price
  • NAII N/A
  • CODX $1.50
  • AVG Volume (30 Days)
  • NAII 4.9K
  • CODX 139.9K
  • Earning Date
  • NAII 02-14-2025
  • CODX 03-13-2025
  • Dividend Yield
  • NAII N/A
  • CODX N/A
  • EPS Growth
  • NAII N/A
  • CODX N/A
  • EPS
  • NAII N/A
  • CODX N/A
  • Revenue
  • NAII $121,853,000.00
  • CODX $7,321,012.00
  • Revenue This Year
  • NAII N/A
  • CODX N/A
  • Revenue Next Year
  • NAII N/A
  • CODX N/A
  • P/E Ratio
  • NAII N/A
  • CODX N/A
  • Revenue Growth
  • NAII N/A
  • CODX 57.16
  • 52 Week Low
  • NAII $4.02
  • CODX $0.65
  • 52 Week High
  • NAII $7.26
  • CODX $2.23
  • Technical
  • Relative Strength Index (RSI)
  • NAII 36.48
  • CODX 43.93
  • Support Level
  • NAII $4.08
  • CODX $0.69
  • Resistance Level
  • NAII $4.19
  • CODX $0.73
  • Average True Range (ATR)
  • NAII 0.11
  • CODX 0.04
  • MACD
  • NAII -0.01
  • CODX 0.00
  • Stochastic Oscillator
  • NAII 8.76
  • CODX 42.31

About NAII Natural Alternatives International Inc.

Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segment. The company derives the majority of revenue from Private-Label Contract Manufacturing which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.

About CODX Co-Diagnostics Inc.

Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.

Share on Social Networks: